Esbriet or Ofev Reduce Inflammatory and Oxidative Stress Markers in IPF, Small Study Shows
News
Esbriet (pirfenidone) or Ofev (nintedanib) treatment in adults with idiopathic pulmonary fibrosis (IPF) led to changes in blood markers reflecting reduced systemic inflammation and oxidative stress after 24 weeks ... Read more